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The assumption of censoring at random for analyses of time to event data in the presence of informative cen-
sorings can lead to a biased estimation of the likelihood and therefore biased estimates in the cox regression.
This thesis presents three different approaches to analyse the sensitivity of time-to-event data to informative
censorings. The censoring at random (CAR) method of multiple imputation via Kaplan Meier imputation
(KMI) serves as a starting point for these methods. On this basis three approaches are introduced and their
implementation in SAS is explained in detail. Finally, all methods are applied to a real world data set and the
results are discussed.
The tipping point analysis adjusts the Kaplan Meier curve of the active treatment group used for the KMI by
raising it to the power of a δ. This δ is gradually increased until the difference in the survival curve of the active
treatment group and the reference group is no longer significant. The smallest value of δ which fulfills this is
called the tipping point. If the resulting tipping point is not clinically reasonable, the original analysis of the
data can be called robust to the CAR assumption [14]. However, it might be the case that no such δ exists, an
example of which is given in the thesis.
The second approach, reference-based imputation, is based on the assumption that from the time point of their
drop out onwards, patients who drop out of the active treatment group have the same risk for having an event
as the patients in the reference group. Under this assumption, KMI for the active treatment group is performed
using the Kaplan Meier curve of the reference group. The aim of this approach is to test if the difference in the
survival curves of the active treatment group and the reference group is still significant after the imputation.
Finally, a pattern imputation approach is introduced. The implemented program allows the user to define
patterns of censored patients who are believed to behave similarly after censoring. For every pattern the ad-
justments to the Kaplan Meier curves for the KMI introduced in the first two approaches can be applied to all
treatment groups. This means every treatment can be imputed by using the Kaplan Meier curve of any treat-
ment and a predefined δ can be applied.
Pattern imputation can be used for sensitivity analyses by making conservative assumptions for the patterns.
It can also give an impression of how the data might look like without censorings if the assumptions for the
pattern are based on realistic reasons.
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heim Pharma GmbH & Co. KG (BI) for giving me the opportunity to write this thesis in cooperation with the
Department of Statistics at the Ludwig-Maximilians-University Munich and BI.
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A Time-to-Event study examines the duration until a predefined event occurs. Originally this event mostly was
death, which established the term survival analysis for this subject area. Today there are far more types of
events that can be examined, for example time until people find a job after graduation or the duration of tool
use until they break for example. This is the reason why the more general term ”time-to-event” is becoming
more common.
If a participant in a time-to-event study leaves the study or drops out for any reason before the event of interest
can be observed, the time when the drop out occurs is recorded and described as censoring.
For the analysis of the data those censorings are usually treated as non-informative or censored at random,
which means they just give the information that the examined event didn’t occur until the observation was
censored. The assumption that the censoring is independent from the eventual event time is necessary for most
of the common evaluation methods like Kaplan-Meier, Cox regression and the log-rank test.
In practise however, drop outs may be not independent from the eventual event time. In clinical trials, par-
ticipants often leave a study because their health deteriorates. In this case it is likely that the event of those
participants would have occurred earlier than the average event time of the other participants. In contrast, it is
possible that a participant feels well enough to leave the country while the study is still ongoing. This would
probably lead to an event time at a later time point than the average. Therefore, censoring may often be infor-
mative.
This informative censoring is analogous to the issue of missing not at random (MNAR) data in longitudinal
clinical trials. In this case, it is assumed that a missing variable not only depends on previously measured
values but also on the true measurements that could not be collected due to the drop out. Those unknown or
unknowable factors affect the outcome of the respective participants of the study. Therefore the assumption of
censoring at random (CAR) which would be analogous to missing at random (MAR) in longitudinal data does
not hold in some cases.
For longitudinal data and if the MNAR assumption is met, several techniques have been suggested to handle
missing data. One approach presented by Ratitch in 2013 [18] is to use adjusted multiple imputation. Multiple
imputation uses the given information of a dataset to define a distribution for the missing variables. This is
sampled multiple times and across those implemented datasets an estimate can be calculated. One form of this
is a pattern mixture model, which allows formation of different patterns depending on factors like time of drop
out, treatment and reason for drop out. All participants with missing variables can then be classified in a pattern
which fits best to the conditions of the participant.
This approach using adjusted multiple imputation was originally designed for longitudinal data. It has recently
been suggested that these ideas may also be transferable to time-to-event data [14].
In this thesis, Kaplan Meier multiple imputation, as described by Taylor et al. [30], will be used as a basis, with
adjustments and/or the pattern-specific modifications created to introduce MNAR assumptions. These will be
used for three approaches for a sensitivity analyses for informative censorings.
The first is a tipping point analysis which worsens the expected time of event in the treatment group step by
step until the difference between the groups is no longer significant.
In the second, a reference based imputation will be used to assume the patients with censorings in the active
treatment arm will not receive active treatment any more and therefore all time points for imputation are drawn
from the curve of the reference group.
1
Chapter 1 Introduction
The third approach is a sensitivity analysis that tries to create a realistic scenario by using informations about
the censorings. This will be done with a pattern mixture model that allows to from different patterns across the






Let T denote the time until an examined event occurs. This event can be death, the failure of a mechanic
machine, the rejection of an organ after transplantation, a job offer or any other event of interest that can be
observed.
More precisely T is a non-negative random variable from a homogeneous population, which can be assumed to
follow a distribution[7]. Commonly, one uses one of the following three formulations to define the distribution
of T mostly unambiguously: the survivor function, the probability density function and the hazard function[7].
They will be explained in more detail later in this section.
One of the characteristics of time-to-event (TTE) data is the fact that the occurrence of the event of interest is
not guaranteed. It is possible, that a participant leaves the study without having an event, which would be the
case if he moves to another country and can’t be followed up for example. Another possibility is that the event
of interest doesn’t occur at all if the occurrence of the event is not guaranteed. It is also possible that the event
happens but not until after the end of the study which means there is an event but it is not recorded because
the study is finished by that time. This loss of information is called censoring and will be explained in the next
section.
2.1.2 Censoring
Censoring occurs if a patient drops out of the study without having the event of interest or if the study ends
before the examined event occurs. In that case, the exact time-to-event is not known for this participant. But the
information, that the participant did not have an event until the time of the censoring still provides information
for the analyses. There are different types of censorings:
Right censoring is defined as follows: Let T ∗i denote the true time-to-event and Ti the observed time-to-event.
Definition 1 (Right censoring).
The time-to-event Ti is right censored, if the observed event time is bigger than a random value Ci, i.e.
Ti = min{T ∗i , Ci} and
θi =
{
1 if Ti = Ci,
0 if Ti = T ∗i
where Ci denotes the time when the variable T ∗i is censored and θi indicates if a censoring or an event
occurred[7].
Right censorings can occur during the study, if a patient leaves without having the event of interest or if the
event did not occur before the end of the study.
For the sake of completeness, it should be mentioned, that there are other types of censoring, which would be
left censoring or interval censoring for example. It is also possible, that more than one type of censoring occur
3
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in one and the same study but this thesis only deals with right censoring and so the others are ignored from this
point.
For most techniques for the analysis of time-to-event data, censorings are assumed to be random or non-
informative. This means that the censorings follow a distribution which is independent from the distribution
of the events. Additionally it is assumed that the Ci’s are independent from each other and the event times
T1, . . . , Tn [7]. This thesis however focuses on the situation of informative censoring. The influence and
assumptions of this type of censoring are explained in more detail in section 2.2.
2.1.3 The Kaplan Meier estimator
The explanations given in this section are based around those given by Collett[1].
Definition 2 (Survivor function).
The function
S(t) = P (T ≥ t),
which is defined as the probability that the time to the examined event of a patient is bigger than some time t is
called the survivor function.
This function can also be expressed as
S(t) = 1− F (t),
where F (t) denotes the cumulative distribution function of T .
To be able to estimate this survivor function, the Kaplan Meier estimator is used. For the calculation of this
estimator the observed event times need to be sorted ascendingly, i.e. the realisations of the event times
Ti, i = 1, . . . , n must fulfil the inequality t(1) ≤ t(2) ≤ . . . ≤ t(n). Although statistically not possible,
due to the discrete recording of the time-to-event, it may happen that in practice multiple censorings and events
are recorded at the same time point which is for example in days.
Let n be the total number of observations. The number of different event times is denoted by r, where r ≤ n
for the reason, that in right censored data not all patients have events and two or more events can be observed
simultaneously. Consequently r different survival times t(1) < t(2) . . . < t(r) are involved in the calculation
of the Kaplan Meier estimator. The amount of patients under risk just before t(j) is denoted by nj . This value
includes those patients which an event at time t(j). The number of patients with an event at t(j) is defined as
dj .
Definition 3 (Kaplan Meier estimator of the survivor function).
Let t(1) < t(2) . . . < t(r) be sorted event times and nj denotes the number of patients under risk just before the








is then called the Kaplan Meier estimator for the survivor function.
It is an estimator for the probability that a patient has no event until the time t(k)
4
CHAPTER 2. THEORETICAL BACKGROUND
2.1.4 The Cox proportional hazards model
The Cox proportional hazards model, or Cox model, is the most common method used to examine the relation-
ship between the time-to-event and the covariates.
It is a semi-parametric model for the hazard rate.
Definition 4 (Hazard function).
Let
S(t) = P (T ≥ t)








Based on this definition, one can develop an estimator for the hazard function.
With the definition of the survivor function and the probability theory of conditional events, the numerator on
the formula of the hazard function can be expressed as
P (t ≤ T < t+ ∆t)
P (T ≥ t)
=

















F (t+ ∆t)− F (t)
∆t
}




Using the fact that f(t) = − ∂∂tS(t), the following relation between the survivor function and the hazard rate
can be established




S(t) = exp{−H(t)} [1]
with H(t) =
∫
λ(t)dt defining the cumulative hazard function.
The Cox model is then defined as follows
Definition 5 (Cox model).
Let zj = (z1j , . . . , zpj) be the vector of the p covariates for the jth individual. The Cox model is defined by
λ(t, z) = λ0(t)e
zβ
where β is a p × 1 vector of unknown parameters and λ0(t) is an unknown function for the baseline hazard
[2].
The baseline hazard gives ”the hazard function for the standard set of conditions z = 0”[2].
5
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Proportional hazards assumption and hazard ratio
The proportional hazards assumption allows the elimination of the unknown baseline hazard in the formula of
the hazard ratio and therefore provides an expression that is independent from time t.
Definition 6 (Hazard ratio).
The ratio of hazards for an individual with covariate vector z∗ compared to an individual with covariate vector
z is given by










This assumption can be used to derive an estimator for the vector of unknown parameters β.
As before, let t(1) < . . . < t(r) be sorted times until the event. Furthermore let R(t(i)) denote the set of
individuals under risk at time t(i), which consists of all individuals that did not have an event or censoring up
to time t(i).
Then, the probability of an event for individual j at time t(i) and di the number of patients having an event at
time point t(i). Assuming only one event can occur at time t(i) is
P (subject j fails at ti|R(t(i)), di = 1)
=
P (subject j fails at ti|R(t(i)))
P (di = 1|R(t(i)))
=
P (tj = t(i)|R(t(i)))











Assuming the event times of different patients are independent from each other, a partial likelihood for β can




















The estimator for β can now be calculated by finding the maximum of l(β). An iterative algorithm which
solves this problem is the Newton-Raphson Algorithm for example [1].
The Cox model gives estimates for the influence of the treatment and other covariates. This means when
comparing the treatment effect a p-value smaller than a predefined significance level indicates a significant
difference between the two treatment groups. The advantage of the Cox model is the possibility to estimate the
hazard rate and under the assumption of proportional hazards allows the comparison of two treatment groups.
The downside however is that the assumption of proportional hazards over time is a strong assumption that
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needs to be fulfilled if the Cox model is used.
The log-rank test is another option for the comparison of treatment effects.
2.1.5 The log-rank test
The log-rank test can be used to compare two groups with each other and examine if there are significant
differences in the group-specific survivor functions, i.e. H0 : S1(t) = S2(t) where Si(t) denotes the survivor
function of group i, i ∈ {1, 2}.
Suppose there are r events t(1) < . . . < t(r) happening across patients in both groups. The amount of events
in Group 1 will be denoted as d1j and in Group 2 as d2j . Furthermore it is assumed that there are n1j and n2j
patients at risk at time t(j) in Group 1 and Group 2, respectively [1]. This sums up to dj = d1j + d2j events
over both groups observed in nj = n1j + n2j patients at risk at time t(j).
The log-rank test compares the expected amount of events in one group under the null hypothesis H0 with the
observed true value at each event time.
The number of events at time t(j) in Group 1, can be regarded as a random variable D1j with possible values
between 0 and the minimum of dj and n1j . The distribution is called hypergeometric distribution which defines










The mean of the hypergeometric distribution is given by
e1j = n1jdj/nj [1],
so e1j is the expected number of individuals with an event at time t(j) in Group 1.





(d1j − e1j) [1].
The mean of this statistic is zero because of E(d1j) = e1j . Knowing that d1j is hypergeometricly distributed,
the variance for one single event time t(j) is given by
v1j =
n1jn2jdj(nj − dj)






v1j = VL [1]
as the event times are independent from each other.
It can be shown, that with a sufficient number of events, UL is approximately normally distributed implying
that UL/
√
VL follows a standard normal distribution
UL√
VL
∼ N(0, 1) [1].
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With the knowledge of the distributions a p-value can be calculated accordingly.
The log-rank test is a powerful tool to test if there are differences between two treatment groups but the only
information it provides is if the difference is significant or not. It is not possible to derive a factor from the
statistic which says patients in group A have x-times later event times than patients in group B.
A different derivation of the log-rank test is given by Peto [16].
2.2 Missing data assumptions
In longitudinal data it happens that values are missing for one or more time points for a patient. The techniques
to analyse the data require different assumptions for the missing data. If a complete case analysis (whereby
subjects with relevant missing data are ignored) is done the missings have to be missing completely at random
(MCAR) to get a valid result. Likelihood-based methods and Bayesian methods require only the less strict
assumption of missing at random (MAR).
Besides this assumption, there is one more type of missingness: missing not at random (MNAR)[25].
The relation between those assumptions and the data can be described as follows. Let Ycom be the complete
data set, which consists by the observed (Yobs) and the missing (Ymis) data. The event of missingness is
represented by the random variable M .
MCAR assumes that the missing is neither dependent on the values observed before the missing (including
covariates) nor on the data that would have been measured, if the missing would not exist,
P (M |Ycom) = P (M).
MAR does not depend on the missing data, but on the observed observations. For the probability of missingness
this means,
P (M |Ycom) = P (M |Yobs, X).
If the distribution depends on both the observed data and the missing data it is called missing not at random,
P (M |Ycom, X) = P (M |Yobs, Ymis, X) [25].
In time-to-event data missing values generally are referred to as censorings. Since for most analysis techniques
the censorings are assumed to be independent from the observed values aka events but not from the covariates
the censoring at random (CAR) assumption can be compared to the MAR assumption in longitudinal data [6].
This means, that the participants who drop out of the study don’t provide any further information about the
event time other than they didn’t have an event until the censoring occurred. Differently spoken, if a subject
drops out of a clinical trial before progression, then it is assumed that, he may have progressed like the average
of the study population.
In practice, however, the censorings sometimes do give informations, which would be called informative cen-
soring.Those informative censorings are similar to the MNAR assumption in longitudinal data since the censor-
ings are not independent from the observed events and the covariates may influence the time of the censoring.
This means, that a patient who leaves the study drops out for a reason directly or indirectly related to the event
8
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of interest. This is for example the case if a patient discontinues from a clinical trial because they feel that the
drug isn’t effective, so they probably would be more likely to experience a (negative) event sooner. Deleting
those cases can bias the outcome of a study. If the benefit of the drug over the reference group is just slightly
significant, when excluding those patients , the superiority may be no longer significant.
As mentioned most analysing techniques assume CAR. The importance of this assumption can be seen in the
calculation of the likelihood where ”the only contribution to the likelihood is just the probability that lifetime T
exceeds” the censoring time [28]. Thus the assumption of CAR in the presence of informative censoring would
bias the likelihood and therefore deliver wrong estimates for β.
One way to deal with informative censoring is imputing the censored values under predefined assumptions
about their behaviour after the censorings.
2.3 Imputation
The explanations in this section are based around those given by Little and Rubin’s ”Statistical Analysis with
missing data” [10]
2.3.1 Single Imputation in Longitudinal Data
Most analysis methods in statistics require complete data, that is values are available for each measuring time
point, each variable and each patient. In practice however, this is rarely the case, i.e. there are missing values
in for longitudinal data or censorings in TTE data respectively. The imputation of those missings or censorings
is one possibility to deal with them.
The term imputation describes the process of filling in reasonable values for the missing values and create
complete data [13]. Up to now, imputation in TTE data is not very widespread but it is used in longitudinal
data commonly. Therefore, in this thesis, imputation methods are described in the framework of longitudinal
data and the extension to TTE data is explained subsequently.
The idea of imputing missing data is relatively straightforward, however there are many ways of doing it and
several difficulties that have to be overcome. The next step is to get different options for its realisation.
Unconditional Means
A simple approach for imputing missing values is the imputing of unconditional means. Let Y = Y1, . . . , Yp
define the matrix of covariates where each column contains one covariate. If Yj = (Y1j , . . . , Ynj) denotes
the vector of measurements for variable j and Ȳj
(j) is the mean of all these values then all values Yij that are
missing are imputed with the mean Ȳj
(j).
This technique preserves the mean of Yj but the variance, which would be v
(j)
j under MCAR and a consistent
estimate of the true variance is [(n(j) − 1)/(n− 1)]v(j)j , where n(j) denotes the number of observed cases and
n the overall number of patients.
This means that by imputing unconditional means, the variance is underestimated by a factor of (n(j)−1)/(n−
1). Also the shape of the empirical distribution is different after the imputation, which can lead to misunder-
standings when studying the data with histograms or other plots.
Last observation carried forward
Last observation carried forward, or LOCF, is applied when no measures follow after a missing value for a
patient. More precisely: if in a study with time points 1, . . . , p patient i has measures Yi,1, . . . , Yi,q with q < p
the last observation Yi,q is used to impute all missing values Yi,q+1, . . . , Yi,p.
9
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Hot Deck Imputation
According to this method, missings are imputed by random sample from the empirical distribution which can
be estimated from the underlying data set. Usually one uses the empirical distribution of the observed values
of the variable only.
If the patients are assumed to show different outcomes depending on an underlying structure of clusters (group/-
stratum), it is possible to calculate a separate empirical distribution function for each group or stratum in the
study and for each missing value draw a random value from the corresponding distribution. On average, the
means remain equal to those of the original data set.
Regression Imputation
If for an individual in a longitudinal data set some values have been observed and some are missing it is pos-
sible to create a model which estimates the missing values using the information given by the observed ones.
The regression model can include information which may not be contained in the distribution of the variable,
such as the correlation with other variables.
The presented imputation techniques are a choice of examples for longitudinal data. The same ideas can
be translated for the application to TTE data to impute censorings and get a complete data set with 100% event
rate and no censorings in theory. In practice, as an extrapolation beyond the end of study date can lead to
serious bias, it is only possible to impute the values for those patients that drop out before the end of the study
but not the ones that are right censored at the end of the study.
2.3.2 Single Imputation in Time-to-event Data
In longitudinal data, missing values do not provide further information. A censoring in TTE data however
gives the information, that the patient has had no event until the time of censoring. So for the imputation of a
censoring, it is important that this is also taken into consideration, i.e. that the imputed event has to be later
than the censoring.
Let T ∗1 , . . . , T
∗
n denote the actual event times of the patients disregarding any potential censorings until the
event happens and C1, . . . , Cn denote the potential censoring times. The value observed in the study will then
be Ti = min(T ∗i , Ci) which means that if the actual event time is smaller than the potential censoring, the time
of the event is captured in the study data but if the censoring has the smaller valueonly the censoring time will
be captured for this patient because the real event time T ∗i is not known[30].
Let nmis = n−nobs denote the number of censorings in the study where nobs is the number of observed events.
The number of patients under risk just after tj is defined by the risk set R(tj) := {i : Ti > tj , i = 1, . . . , n}.
For imputing censorings equivalent techniques as for the longitudinal data can be used. The mean life time
could be estimated and inserted for each censoring, which would be an equivalent to the unconditional means
imputation. The methods explained in the following for TTE data are related to the hot deck imputation. The
basis for both of the examples is to calculate a distribution derived from the current risk set for each censoring
[30].
Risk set imputation
The data set contains nmis censored times tj that should be imputed. For each of these missings, a pair (t+i , δi)
is randomly drawn from the risk set R(tj) of t(j). All pairs (t
+
i , δi) in the risk set are drawn with equal
probability, the event times as well as the censored times. A censoring that has been imputed again with a
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censoring (t+i , 1) will not be imputed a second time but stay a censoring at a later time. The censorings will
be imputed ascendantly, beginning with the one that occurred first in the study. If the last observation is a
censoring it will not be imputed due to the reason that there are no pairs of observations in the risk set [30].
Kaplan Meier imputation
Kaplan Meier imputation (KMI) calculates a separate survival curve for every censoring and imputes the cen-
sored value by drawing a random value from the survivor function.
Analogously to the risk set imputation, the procedure begins with the smallest censoring time and the censor-
ings are imputed ascendantly. For each censoring time ck, an individual survival curve Ŝ(ck) can be calculated
on the basis if the corresponding risk set R(tk)[30].
Therefore, it is assumed that the study includes M observed events at distinct times (t1 < t2 < . . . < tM ) and
K distinct censoring times (c1 < c2 < . . . < cM ). It is also assumed that there may be more than one patient
with the same times at risk yi, which means ties are allowed.
For calculating the individual survivor functions, let k index the censoring times and tk,0 denote the latest fail-
ure time prior to ck (or equal to it) when t1 ≤ ck. If t1 > ck then let tk,0 = 0. The jth failure time after ck
is denoted tk,j , j = 1, . . . , Jk, when ck < tk. From the data (Yi, θi) the Kaplan-Meier estimates Ŝ(t(k)) fot
the survivor distribution can be calculated. For a censoring time ck followed by at least one failure time, the






(tk,1 − ck)Ŝ(tk,0) + (ck + tk,0)Ŝ(tk,1)
(tk,1 − tk,0)
[35]
The survival curve gives the probability of not having an event up to a certain time and therefore takes values in
the interval [0, 1]. This characteristic is used to find an imputation time by generating a realisation of a uniform
(0, 1) value and reading the corresponding t+i from the estimated survivor function [30] [35].
This procedure is valid as long as the resulting t+i is smaller than the largest event time. However, it is also
possible to produce a value beyond the largest event time. In this case the censoring is imputed as a censoring
at the last observed event time. Censorings that happen after the last event are not imputed because there are
no events left to construct a survival curve. The imputed values are not used to calculate the survival curves
for the subsequent censoring times. They are saved in a separate data set and used to replace the corresponding
censorings after the complete imputation process is completed [30]. Finally, a TTE analysis can be done as
planned before imputation.
In practise imputations in TTE data are not very common. This is due to the reason that until recently it
has been believed that there are no real benefits for using it: The original data can be analysed with methods
valid for CAR and this also applies for the imputed data.
2.3.3 Delta adjustment
Zhao et al. [35] proposed an extension to the Kaplan Meier imputation introduced in Taylor et al. [30].
In this, a fixed hazard ratio δ for a patient who drops out of the study before having an event is introduced
relative to the patients still remaining on their assigned treatment is introduced as the sensitivity parameter.
The estimated survivor function at time t is equals Ŝ(t)δ under the proportional hazards assumption. For a
11
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patient with censoring at time ck < tM , the estimated conditional probability of having an event in the time






After defining this probability the conditional cumulative incidence function for a censoring at time ck to have










With this formulation, δ > 1 (or < 1) implies a higher (or lower) hazard after ck for patients censored at that
time point compared to patients still under risk at ck.
For the reference group the δ after the drop out is considered to be lower compared to patients who disband
from the active treatment group. Assuming δp = 1 would imply a CAR like behaviour after the drop out for the
reference group. This way the hazard in the active treatment group becomes the only parameter for calibrating
the sensitivity analyses δT = δ [35]. The realization of this delta adjustment is done by using the conditional
incidence function instead of the survivor function Ŝ(ck) in the Kaplan Meier imputation.
2.3.4 Multiple Imputation
Since the single imputation methods cannot take into consideration the uncertainty in the data and for some
imputations adjustments are anyway necessary to get appropriate results, the multiple imputation approach is
one possibility to deal with this [10][17][22][23][24].
Multiple imputation is done similar for longitudinal and TTE data. The idea is to impute a data set M times
using a single imputation technique that uses a random distribution and to combine the calculated estimates
from the imputed data sets [30]. This combination is usually done by means of Rubin’s rules which require
normal distribution of the estimates.
Let θl, Vl, l = 1, . . . ,M be the M estimators and variances resulting from the single imputations, i.e. one pair
(θl, Vl) denotes the estimate of interest and its variance. In longitudinal data this could be a point estimate
and for TTE data this could be the log hazard ratio. The combined estimate for θ1, . . . , θM is the mean of all
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In case of TTE data the variances V̂l are calculated using the Greenwood formula [4].
If θ is a vector, (·)2 is replaced by (·)T (·). The total variance of θ̄ is then given by the sum




If θ is a scalar the distribution to be used for interval estimates and significance tests is a t-distribution,
(θ − θ̄)T−1/2 ∼ tv [10][30],
where v denote the degrees of freedom









As the singly imputed values are drawn from the distribution of the observed values or events when imputing
TTE data, the mean of the imputed values is similar to the mean of the observed ones as long as no covariates
are included in the imputation process. Hence, the mean of the estimates θ̄ does also not change after imputation
under the assumption of CAR [10].
Multiple imputation has the positive characteristics of the single imputation which means the same estimates
are produced and attempts to correct for the disadvantages especially the underestimation of the variance by
repeating the single imputation step multiple times [10].
2.4 Pattern mixture models
As mentioned before, the reason for drop out can be independent of the response and treatment or linked to
them in some way. A pattern mixture model incorporates patterns for groups of patients that are believed to
behave similarly after a drop out. Therefore M represents an indicator vector where the i-th element is 0 if
an actual event is observed and 1 if it is a censoring. Y denotes the matrix of outcome data composed of the
missing Ymiss and the observed data Yobs [8][9].
A pattern mixture model allows to express the joint probability of Y and M by means of conditional probabil-
ities:
P (Yobs, Ymis,M |X) = P (M |X)P (Yobs, Ymis|M,X) [9].
In this formula P (M |X) represents the ”conditional probability distribution of missingness”[18] based on
the matrix of observed covariates. The probability distribution of Y conditioned on M and X is denoted by
P (Yobs, Ymis|M,X).
The problem is, that some parts of P (Yobs, Ymis|M,X) can not be estimated. Explicitly it is not possible to
derive a relationship between Ymis and X , due to the non-existence of Ymis[18].
There are some approaches in literature which deal with this issue. One of them splits up the probability
distribution as follows:
P (Yobs, Ymis,M |X) = P (M |X)P (Yobs, Ymis|M,X)
= P (M |X)P (Yobs|M,X)P (Ymis|Yobs,M,X) [18]
The term P (Yobs|M,X) is a model for the observed data conditioned on the patterns of missingness M and
the matrix of explanatory variables X , whereas P (Ymis|Yobs,M,X) presents the model for the missing data
depending on M,X and the observed data Yobs.
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A pattern mixture model can be implemented as follows[13][18]:
• Choose patterns with similar characteristics or reasons for missingness/censoring
• Specify a link between the distribution of unobserved/censored data and the distribution of data where
the corresponding data items are observed
• Estimate one or more models on the basis of the observed data
2.5 Bootstrap
The main goal of bootstrapping is to estimate the distribution, variance or bias of a random variable T (X,F ),
which depends on the random sample X = (X1, . . . , Xn) and an unknown distribution F . It is assumed that
the random sample follows the distribution F,
Xi = xi, Xi
i.i.d.∼ F i = 1, . . . , n
where x = (x1, . . . , xn) is a realisation of X [3].
Hence bootstrap is used if the sample size is small and it’s difficult to make a statement about eventual asymp-
totic behaviour or if no parametrical assumptions should be met.
The bootstrap is based on repeatedly resampling the observed data and estimate the parameters of interest from
those ”bootstrap samples”[3].
The principle of the bootstrap method is as follows:
• Construct the sample probability distribution F̂ , with equal probability mass 1/n for each data point
x1, x2, . . . , xn.






i.i.d.∼ F̂ i = 1, . . . , n.
• Call this the bootstrap sample X∗ = (X∗1 , . . . , X∗n) and x∗ = (x∗1, . . . , x∗n) its realisation [3].
Since the sample is selected with replacement, observations from the original data can be included once,
multiple times or not at all.
• With this bootstrap sample at hand, the measures of interest can be estimated by means of an approximate
statistic T ∗(X∗, F̂ )
x∗ = (x∗1, . . . , x
∗
n)→ T ∗(X∗, F̂ )
All of these steps are repeated B times, leading to B bootstrap samples x∗1, . . . , x∗B and B estimates for the
value of interest T ∗1, . . . , T ∗B[3].
With those statistics the characteristics of the distribution of T can be estimated. For example the variance
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The connection between the so called ”bootstrap world” and the real world with the observed data is described
by the following graph
Real World
F → x = (x1, . . . , xn)
?
θ̂ = T (x)
-
Bootstrap World
F̂n → x∗ = (x∗1, . . . , x∗n)
?
θ̂∗ = T (x∗)
The unknown distribution F gives the observed data x, which can be used to calculate the empirical distribution
function F̂n. The empirical distribution function in its turn gives the bootstrap samples by means of resampling.
The realisation of the statistic T (x) is part of the real world and can be estimated from the observed data x,
whereas the bootstrap replication of T (x), T (x∗) is calculated using the bootstrap sample.





Macros for censoring at random
The assumption of censoring at random is made in most TTE analyses. This means that the events and censoring
happen independently from each other and are independent of what has been observed or will be observed.
Hence, the outcome will remain unaffected.
Using a multiple imputation method on random censored observations to replace them by events should lead to
the similar results as the original not imputed data. For this reason a multiple imputation is not that useful since
it requires more work for the same outcome and introduces a small amount of additional variance (dependent
upon the number of imputations) from the multiple imputation technique itself.
But a macro imputing random censorings can also be used as a basis for a program to deal with informative
censorings. Therefore the following macro which imputes under a censoring at random assumption is presented
as a starting point for the subsequent ones applicable for the case of informative censorings.
3.1 Data
For the implementation and the results of the different imputation approaches presented later the LUX-Lung
3 oncology study serves as a practical example. This section introduces the example data set, explains the
structure needed by the macro to work correctly and shows examples of the results.
Example study
To introduce the data set an excerpt from the publication of the study is given here:
”LUX-Lung 3 was a global, randomized, open-label phase III study comparing first-line afatinib with cisplatin
plus pemetrexed chemotherapy in patients with advanced lung adenocarcinoma and proven EGFR [epidermal
growth factor receptor] mutations. The primary end point was PFS [progression-free survival], defined as time
from random assignment to progression (as determined by independent blinded review) or death”[27].
The study included 345 patients with advanced lung adenocarcinoma and confirmed EGFR mutations. Those
were randomly assigned to treatment in a two-to-one fashion which leads to 230 patients in the treatment group
and 115 patients in the reference group[27]. The overall censoring rate is 28.7% which corresponds to a total
number of 99 censorings divided into 54(23.48%) in the treatment group and 45(39.13%) in the reference
group.
The analyses were done via a stratified log-rank test and Cox proportional hazards models. The stratification
factors for the log-rank test are EGFR and race (Asian or non-Asian). The Cox model included the same
stratification factors and additional model covariates such as sex, age and smoking status. The results presented
in this thesis were calculated from a data set containing only EGFR and race as covariates.
3.1.1 Structure needed for the macros
Most characteristics of the input data set can be directly detected and appropriately handled by the macros.
Only minimal information needs to be handed over in the call of the main macro, e.g. the names of the data
set and the treatment and censoring names variables don’t need to be of a certain form but are to be specified
in the corresponding argument. Also the stratification factor names need to be entered in form of a list for the
17
CHAPTER 3. MACROS FOR CENSORING AT RANDOM












The other arguments define what the program is doing during its execution. The ”seed number” represents a
fixed number for all random procedures in the macros to offer the possibility of reproducing the results. The
”separate=” statement steers the option to do the imputation separated only by treatment (separate = NO),
or by all stratum groups (separate = Y ES) given in the ”Stratum” argument. The same applies to the
analyse statement: choosing Y ES means all covariates are included in the model for the analysis, using
analyse = NO forces the program to only use the treatment effect in the model. The value for the refer-
ence group can be any number in the range of the amount of treatments, it is not allowed to be a letter in this
program, the Ref = statement allows the user to specify the code of the reference group. The btloop = line
gives the number of data sets that should be imputed and the bt statement enables the user to decide whether a
bootstrap is wanted or not. The last command asks if the analysis should be done by Cox proportional hazards
model or by a (stratified) log rank test.
The program is structured in 5 macros with different objectives. The %main(·) statement calls the macro
with the same name. The Adjustment macro finds its use in chapter 4 and will be explained in the mentioned
chapter. The other three macros, curves, imputation and analysis are introduced in the course of the next section
containing the explanation of the whole program.
The next sections explain how the information entered in the %main(·) statement is used to do the multiple
imputation with the assumption of non-informative censoring.
3.2 The program
3.2.1 Preparations
The main macro transforms the data sets to the right structure and extracts the information that is needed to do
a multiple imputation.
Before the actual imputation process can be started, some preparations are necessary, beginning with the import
of the data set defined in the call of the macro. The next step is to define one variable which contains the number
of treatment groups as well as the number of stratum groups in the case of separate imputation. In this case,
the treatment group numbers and the stratum group numbers are combined into a single, separate variable. An
example for a data set with 2 treatment and stratum groups each is displayed in table 3.1.
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Treatment 1 Treatment 2
Stratum 1 1 3
Stratum 2 2 4
Table 3.1: Example of the enumeration of the strat variable under stratified imputation
The encoding is chosen such that all stratum groups in one treatment group are imputed one after the other
before the loop for the next treatment begins. If no stratified imputation is planned the variable strat is instead
set equal to the treatment variable but it is defined either way so the program can work with the same variable
regardless of the Separate= statement. This is a useful detail in the next chapter where the imputation proce-
dure is modified for some of the treatment groups.
The newly defined strat variable can then be used by the program to determine the number of different groups
that need to be imputed, each of them according to a separate Kaplan Meier curve. For each of the groups, a
separate data set is created which only contains the censorings within this group. These censored data sets are
used later on to replace the censoring times with the imputed event times. Taking up the previous example of 2












Figure 3.1: Example of the creation of the censored data sets in the case of 2 treatments and 2 strata
These steps only need to be conducted at the beginning of the program. Once the censored data sets have been
created and the information about the number of groups has been determined, the group-specific Kaplan Meier
curves for the imputation can be calculated. This is done via the curves macro which is called by the main
macro at this point. The remaining steps in the main macro are described at a later point of this thesis for the
sake of better understanding.
3.2.2 Calculation of the Kaplan Meier curves
The curves macro calculates the Kaplan Meier curves that are used in the subsequent imputation process. This
can be done with or without bootstrapping.
If no bootstrap is used, the multiple imputation is done by means of the same KM curves which are calculated
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per treatment group and per stratum from the originally supplied data set.
If a bootstrap is intended to be done, some preparation steps are necessary before the actual imputation can
begin.
As stated before, each bootstrap sample contains a different set of observations. Therefore the Kaplan Meier
tables for each data set are different. At this stage, the KM tables are calculated for each treatment (by stratum if
necessary) in each bootstrap and stored in a data set. One imputation will be based on the KM curves estimated
for each bootstrap sample. Hence, the number of bootstrap samples has to be equal to the number of single
imputations.
The benefit of using a bootstrap is to obtain a better estimate for the variance. Without the bootstrap, the
variance would be understated as the KM curves used in the imputation are derived from the sample data and
not the population. This paragraph gives a short overview of the bootstrap implemented in the macro.
The macro uses a bootstrap with replacement, which draws as many observations from the original data set
as are contained in the original one. This means that in one bootstrap sample, some observations are included
multiple times, some only once and some are not included at all. Each data set that is going to be imputed from
is build by a bootstrap and they are therefore all slightly different to each other.
Furthermore the number of events and censorings differ across the bootstrap samples and therefore they also
differ in the treatment and stratum groups. The imputation macro imputes all censorings that occur before the
last event. Since every group may have a different final event time in each bootstrap sample, the curves macro
must also calculate the number of censorings that can by imputed in every group prior to the actual imputation.
3.2.3 Kaplan Meier imputation
Once all censorings are available in data sets, separated by their treatments (and, if required, strata) and the
corresponding KM tables have been determined the actual imputation can be conducted by means of the impu-
tation macro. It can impute any arbitrary data set if the Kaplan Meier curves for each group, the censoring data
sets, the variable name of the time variable, the number of strata and the name of the censoring variable are
entered as input parameters. As mentioned in the theoretical background 2.3.2 Kaplan Meier imputation is one
method to impute a TTE data set. It uses the calculated KM tables to create a random event according to the
KM curve created by the current KM table. Prior to the description of how the imputation was implemented in
the macro, the KMI will be explained by means of an example.
(a) Original Data (b) Data with ept >= 211
Figure 3.2: Example of KMI for a censoring at day 211
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Figure 3.2a shows the Kaplan Meier curves for the original data set separated by treatment group. The cen-
soring, which is circled in the left plot, is the one to be imputed at day 211. In a first step, all observations
<= 211 are excluded and the Kaplan Meier curve is recalculated on the basis of the remaining observations
(see figure 3.2b). Suppose the generated random uniform [0, 1] value is 0.52. The corresponding upper black
line intersects with the Kaplan Meier curve at day 499 which will be the imputed value. The second black line,
representing another random uniform variable, does not intersect with the Kaplan Meier curve at all. In this
case imputing an event is not possible so the censoring will be replaced with a censoring at the last observed
event in the corresponding group.
Having this example in mind, the explanation for the implementation of the KMI in the macro is given in the
following.
First the program needs to know how many censorings need to be imputed in the present strat group. If there
are censorings later than the last event in this group, these can’t be imputed because there are no following
events which can be used to calculate an appropriate Kaplan Meier curve. Therefore the program identifies the
last event in the strat group and based on that determines the last censoring that can be imputed. The censoring
data sets are arranged in ascending order by the censoring times and therefore the sequential number of the last
censoring that should be imputed can be used as upper limit of the imputation loop.
The imputation starts by extracting the identification number and the censoring time of the first censoring from
the first censoring data set. A corresponding new KM table is created by deleting every event or censoring
prior to the censoring to be imputed within the treatment/stratum group the censoring belongs to. The remain-
ing survival probabilities are divided by the first value so the biggest value in the table is 1 again. This new
calculated KM table has the same characteristics as any other KM table calculated by a Kaplan Meier estimator.
In particular, the range of the risks are between [0, 1] as they represent the probability of not having an event
until the corresponding time. This fact is used to generate an imputation time by drawing a random uniform
[0, 1] value denoted by b. In SAS this can be realized by means of the Call Ranuni routine. According to the
example above there are two possibilities of how the imputation is done:
1. If there is a value smaller than b in the KM table, the time corresponding to the largest value less than b
is saved as the imputed time. Additionally, the variable censoring variable is changed from 1 to 0 which
means the imputation is treated as an event in the following analysis.
2. In case b is smaller than every probability in the KM table the censoring cannot be imputed as an event
because there is no corresponding time for this particular random number. In this case the latest observed
event time available within the corresponding treatment/stratum group in the present bootstrap sample is
saved as the imputation time for this censoring. The variable for the censoring remains 1. This means the
censoring is still a censoring after the imputation but it occurs at the latest event time in the corresponding
treatment/stratum group.
With the imputed time and the adjusted censoring variable, the observation can be saved in a data set that
contains only imputed observations and is used to replace the censored data sets later on.
These steps need to be performed for all censorings in all treatment/stratum group with one exception. For
censorings occurring later than the last event time there is no possibility to calculate a Kaplan Meier estimate
due to the lack of events. Those censorings are not imputed and transferred unchanged to the imputed data set.
At this stage, imputed data sets are available for every treatment/stratum censoring data set. The next subsection
describes the combination of the separately imputed data sets and the subsequent analysis of the resulting data
sets.
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3.2.4 Analysis of a singly imputed data set
The combination and analysis of the imputed data sets is done in the analysis macro.
The output of the imputation process comprises separate data sets containing the imputed censored values for
the specific strat group. Those data sets are combined in one data set containing all former censorings, most of
them imputed. At this point, all events from the current data set can be extracted and combined with the data
set with imputed events. The result is a singly imputed data set with the same number of observations as the
original data set and comprising almost entirely events. The reason for an event rate of less than 100% in spite














Figure 3.3: Example of the combining of the imputed data sets
Figure 3.3 continues the previous example with 2 treatment groups and 2 stratum groups and shows a schematic
of the combination of the 4 imputed data sets to the final imputed data set.
This imputed data set can then be analysed analogously to a non-imputed data set. The macro includes imple-
mentations of the Cox proportional hazards model and the (stratified) log-rank test. If the analysis is planned
to be stratified the stratification factor will be included as strata statement in either the lifetest or the phreg
procedure. For the log-rank test the treatment variable is entered as test statement. The Cox model includes the
treatment variable as covariate. The results are saved in a data set.
The procedure described above leads to one imputed data set and the results from its analysis. As mentioned
the analysis is implemented in the analysis macro which includes all steps that need to be done for every sub-
sequent data set in one loop. This loop is done for each of the B data sets. All results from the analyses of the
imputed data sets are saved in a data set so they can be pooled in the main macro.
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3.2.5 Combining the results
The final steps of the program are implemented in the main macro again. Once all B singly imputed data sets
are analysed separately by means of the above mentioned methods, the results need to be combined across
imputations. For normally distributed variables, this can be done via the SAS procedure MIANALYZE. The dis-
tribution requirement is met for both, the log-rank statistic UL derived in section 2.1.5 and the log-transformed
hazard ratio, at least approximately [15].
The MIANALYZE procedure calculates the pooled mean as well as the standard error for the variables inserted
in the modeleffects statement. It also calculates a 95% confidence limit and the p-value for the hypothesis of
the variable being different to 0.
After the detailed explanations of the single steps implemented for a multiple imputation procedure, figure 3.4
provides an overview over the structure of the whole program.
The flowchart reveals that the program is straightforward and only branches to offer more flexibility for the
imputation.
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Import data
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separated by treatment & stratum
Bootstrap?
Create KM table for original 
data set via proc lifetest
No
Create B bootstrapped samples 
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imputed for each treatment & stratum group
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censoring and rebase probabilities to start with 1
Generate uniform (0,1) value 
via call ranuni -> b
Is b smaller than min survival
probability in KM table?
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corresponding to probability b
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Replace time of censoring
with imputed time
Set censoring variable to 0 Set censoring variable to 1
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with censoring only
Replace time of censoring
with imputed time
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Create data set containing only events
from current bootstrap sample (no imputed events)
Combine these with imputed data set 
-> comlete data set with imputed events
Analyse the complete data set with (stratified) 
 log-rank test or Cox model with predefined model 
Save analysis results for each bootstrapped 
data set in data set
If neede, transform results to normal distribution
Pool analytic values via MIANALYZE
Main macro Curves macro
Imputation macro Analysis macro
Legend
Figure 3.4: Flowchart of CAR macro
3.3 Results
The macro produces B imputed data sets from the original data set where B denotes the user specified number
of bootstrap samples. Additionally it returns outputs of the MIANALYZE procedure.
The imputed data sets can be pooled to an overall data set with B times the population of the original dataset
and compared to the original data set. This comparison is done to show that no bias is introduced by imputing
the censorings. All imputations in this Thesis are done 100 times with Seed = 1111. The first approach is the
comparison of the resulting Kaplan Meier curves.
Figure 3.5a shows the Kaplan Meier curves calculated on the basis of the imputed data set and the original data
set respectively, both separated by treatment. The respective curves almost coincide. The jumps in the curves
for the imputed data sets are located at the same time points as the ones in the original curves. This is caused by
the fact that the imputation produces more events but not more event times, since the censorings are replaced by
already existing event times. The survival times of censored observations that could not be imputed as events
generally fall on the last 10-15 event times. The usually do not fall on earlier event times because the KMI
only imputes as censoring if the generated random number has a smaller value than the smallest probability in
the KM table corresponding to the last possible event time in the current KM table. The variation within the
survival times that remain censored is due to the use of bootstrap samples which can have differing last event
times.
The right figure 3.5b shows the curves after imputation separated by treatment and stratum. Those curves dif-
fer more clearly than in 3.5a. This can be explained on the basis of table 3.2 which is presenting the patient
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(a) Imputation by treatment (b) Imputation by treatment and stratum
Figure 3.5: Imputation under CAR
numbers per stratum.
Treatment Reference
Stratum 1 2 3 1 2 3
Observations 91 112 27 47 57 11
Events 72 80 24 26 35 9
Censorings 19 32 3 21 22 2
Table 3.2: Number of patients by treatment and stratum
Especially from stratum 3 within treatment 2, it is observable that some stratum groups are very small and the
difference between the curves of the original and the imputed data is a consequence of these small group sizes.
However, the graphs are still very similar such that also the descriptive statistics prior and after the imputation
shouldn’t deviate much from each other. The Quartiles of the original and not stratified imputed data sets are
displayed in table 3.3.
Original Imputed
Treatment Reference Treatment Reference
25% Quartile 162 93 162 93
Median 340 210 340 210
75% Quartile 586 333 586 330
Table 3.3: Comparison of Quartiles of observation times under CAR
The numbers for both treatment groups coincide quite well which is another strong hint that the imputation
preserves the distribution in the different groups.
The next step is to examine the analysis methods for TTE data which are implemented in the program.
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Hazard ratio
Value Lower CI Upper CI Score p-value
Original 0.5712 0.4283 0.7617 3.8128 0.0001
Imputed 0.5591 0.4140 0.7552 3.80 0.0002
Log-rank test
Value Lower CI Upper CI Score p-value
Original -23.115 -34.8580 -11.3719 -3.8589 0.0001
Imputed -35.3103 -52.8746 -17.7460 -3.95 <.0001
Table 3.4: Comparison of analytical values under CAR
Table 3.4 presents the results of the hazard ratio and log-rank test without stratification for the original and the
not stratified imputed data set. The scores for the original data are z-scores, whilst the ones for the imputed data
sets are t-scores. If a hazard ratio is equal to 1 the hazard in the active treatment group is the same as that for
the the reference group which means the active treatment shows no effect. A hazard ratio < 1 shows a reduced
hazard in the active treatment group compared to the reference group.
The values of the hazard ratio are close to each other but those of the log-rank statistic differ clearly. The reason
for this can be identified by looking at the formula of the log-rank test (chapter 2.1.5). As the test statistic takes
into account the number of events and the imputed dataset has more events than the original one since most
of the censored values have been imputed, this implies a difference in the denominator. The p-values of the
log-rank test however can be compared after the pooling by the MIANALYZE procedure [35].
To ensure that the differences of the log-rank statistics are due to the increase of events and not caused by an
error in the macro, an equivalence test was performed upon a set of simulated data.
3.4 Equivalence test
The aim of this test is to demonstrate that the results for the log-rank test are not biased by the conduct of an
imputation process as described in this chapter.
A pair of simulated data sets were provided: the first does not contain any censorings; the second one is iden-
tical to the first data set but is censored at random with a censoring rate of approximately 20%. The data sets
contain 100 sets of simulated trial data with 2000 patients (1000 per treatment group). Both the event times
and the censoring times follow an exponential distribution but with different parameters. The parameters of
the exponential distribution are chosen in order to end up with ≈ 20% censorings in each of the 100 trial data
sets. Those data sets were provided for usage in this thesis by an external source and not created by the author.
Those two data sets offer the possibility to compare an imputed data set to its ”true” version.
The CAR macro was used to impute the censored data set. The results were then compared to those from the
complete data set.
Since the use of the CAR macro will result in an imputed data set with ≈ 1% censorings, the remaining cen-
sored values will be copied to the complete data set after every imputation. Hence, both data sets have the same
number of events and therefore the log-rank statistics are comparable.
The log-rank statistic of the complete data set is calculated by means of the LIFETEST procedure after the
remaining censorings are taken over from the imputed data set. The imputed data sets are analysed with the
same procedure.
Finally, 100 log-rank statistics are obtained for the complete and the imputed data sets, respectively. To deter-
mine if there is a significant difference between both those statistics, a two one-sided t test (TOST) is performed
via the TTEST procedure.
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The mean of the LR statistics for the complete data sets is −356.85. Therefore, the margins are defined as
θL = −3.5 and θU = 3.5 for the TOST in this case because this allows approximately 1% divergence for the
mean of the LR statistic for the imputed data set relative to the means of the log-rank statistics of the complete
data set.
The summary of the mean difference and the results of the TOST is displayed in tables 3.5 and 3.6.
Mean 95% CL Std Dev Minimum Maximum
-1.0419 -2.9299 0.8461 10.3293 -20.3197 23.7095
Table 3.5: Summary of the mean difference between log-rank tests of imputed and complete data sets
The difference between the means of log-rank tests of the different data sets is −1.0419 which is very small in
relation to the absolute values of the test statistics. The fact that the confidence interval includes zero reassures
that the statistics are not different, but does not eliminate the possibility that there is simply insufficient data.
Mean Lower Bound 90% CL Upper Bound Assessment
-1.0419 -3.5 < -2.6218 0.5380 < 3.5 Equivalent
H0 DF t-Value p-value
Upper -3.5 99 2.58 0.0056
Lower 3.5 99 -4.77 <.0001
Overall 0.0056
Table 3.6: TOST Level 0.05 Equivalence Analysis
Table 3.6 shows the results of the TOST equivalence analysis for the Null hypothesis H0 : ∆ < θL or ∆ > θU
vs. the alternative hypothesis HA : θL < ∆ < θU where ∆ denotes the difference in the LR test statistic and
θL and θU are the predefined lower and upper equivalence margins.
The TOST procedure consists of two separate tests (H01 : ∆ < θL, H02 : ∆ > θU ) and consequently, the
test results comprises two p-values. The given results reveal that both null hypotheses can be rejected and the
overall p-value of 0.0056 also signifies the equivalence of the LR test statistics at a significance level of 5%.
The theory for the TOST is taken from [26] and [32].
This equivalence test shows that the difference observed in the log-rank statistic can probably be explained
by the increased number of events in the imputed data set. If a log-rank test is used the comparison has to be
done with the p-values.
Table 3.7 reveals that the hazard ratios of the censored, the uncensored and the imputes data sets are very close
to each other as well as the t-scores and the p-values. For the log-rank test, the censored data set which has less
events has a clearly different log-rank statistic. However, the t-scores and p-values are close to each other and
can be compared.
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Hazard ratio
Value Lower CI Upper CI Score p-value
Original censored 0.4265 0.3663 0.4965 11.01 <.0001
Original uncensored 0.4291 0.3724 0.4945 11.73 <.0001
Imputed 0.4264 0.3640 0.4996 10.61 <.0001
Log-rank test
Value Lower CI Upper CI Score p-value
Original censored -287.6332 -334.765 -240.501 -11.99 <.0001
Original uncensored -356.846154 -408.093 -305.599 -13.68 <.0001
Imputed -357.8880 -412.221 -303.555 -12.95 <.0001
Table 3.7: Comparison of analytical values for equivalence
This program also shows that the CAR multiple imputation program works correctly and produces results that





The previous chapter described the structure of a Macro which imputes censored values under the assumption
of CAR. By making some changes, this program can also handle informative censoring. Three different ap-
proaches to do this were realised in this thesis: tipping point analysis, reference based-imputation and pattern
imputation.
4.1 Tipping point analysis
The Kaplan Meier curve estimates the probability of not having the event of interest up to a certain time point.
In case CAR is assumed, a censoring only causes a reduction of the number of patients under risk at the time
of drop out.
For the following sensitivity analyses, it is assumed that individuals in the treatment group who drop out of the
study would actually do worse than the average of individuals in this group. This assumption is based on the
thought that patients leave the study because they don’t feel any benefit from the treatment and therefore either
think the treatment is not working properly or that they may have been assigned to the reference group. That
is, the censoring is not at random, but depends on the treatment effect.
The idea behind the tipping point analysis is to take each probability estimated for the Kaplan Meier curve to
the power of a predefined factor δ. Since probabilities are always in the [0, 1] interval, taking the probabilities
to the power of δ leads to a reduction assuming delta is greater than 1 [14][35]. This δ can be interpreted as an
increased hazard after the patients drop out of the study. For example, if δ = 2 the hazard for an event at time
t is twice as high compared to the patients who remain in the study [35].
The goal of the tipping point analysis is to find the smallest value of δ that worsens the Kaplan Meier curve of
the treatment group such that the difference between the survival curves of the treatment and the reference is
no longer significant. If the δ does not seem clinically reasonable, the results can be called robust to the CAR
assumption [14].The implementation of this approach only demands slight modifications of the CAR macro.
In advance of the actual imputation process, all survival probabilities in the KM tables of the active treatment
groups need to be taken to the power of the predefined δ. All groups apart from the reference group will be
adjusted with the same δ. This is especially important if the imputation is done separated by stratum or if
there is more than one active treatment group. In spite of these changes, the basic CAR imputation can still be
reproduced by setting δ equal to 1.
4.1.1 Implementation
The implementation of this δ in the program is done via the previously mentioned adjustment macro. This
macro is able to realize all the changes that are necessary for the tipping point analysis as well as for the next
approach. It is called directly after the Kaplan Meier curves have been estimated for the respective data set.
The changes are always done only to the Kaplan Meier curves which are used to find the imputation time, and
not to curves calculated for an analysis.
The former CAR program that now includes the adjustment Macro can be called via a parental Macro which
increases the δ for every run stepwise until the p-value exceeds a pre specified significance level or a maximal
31
CHAPTER 4. INFORMATIVE CENSORING
number of runs has been reached. The call statement of the tipping point Macro differs only slightly from the















The level= statement allows the user to specify a specific 2-sided significance level for the treatment effect
which is by default 0.05. The maxdelta= argument offers the possibility to have a maximum δ at which
the tipping point analysis stops. This is needed because it is not guaranteed that the difference between the
treatment groups can fall below being significant even for an infinite δ. The start statement is used to specify
an initial value for δ and the by= option allows the user to define the step width for the sequential increase of
δ. The value for δ does not need to be an integer, it can have any decimal number. The recommendation is to
run the macro first only with integers and after the tipping point is identified to be in the interval [x, x+ 1] the
macro can be run again starting with a starting value x, a maximum of δ = x+ 1 and a step width of 0.1. Thus,
the tipping point can be found correct to one decimal place. As before, all imputations were done 100 times.
For the tipping point analysis each result for one δ is calculated using 100 data sets.
4.1.2 Results
In order to find a δ which makes the difference between treatment groups not significant, the macro is applied
to a subgroup of the original study. The reason why the original data set could not be used entirely will be
explained later on in this chapter. The subgroup consists of patients with EGFRST equals 1 or 2. This does
not have any clinical reason it is only to be able to present the functioning of the tipping point analysis. The
resulting study population consists of an overall of 207 patients. The active treatment group includes 139
patients, 55 of them censored. The reference group consists of 68 patients with 18 of them dropped out. This
subgroup is only used to demonstrate the functioning of the tipping point analysis.
Before showing the results of the tipping point imutation the difference between the Kaplan-Meier curves for
the KMI are displayed for several δ’s.
Figure 4.1 displays the Kaplan Meier curves of the active treatment group taken to the power of 1, 3 and 5. To
give an example of how much the choice of δ affects the curves, a dotted line is drawn at 50%. For δ = 1
the intersection of the KM curve with this line is at day 339 which can be interpreted as the probability of not
having an event until this day is 50%. For δ = 3 and δ = 5 the 50% mark is reached at days 122 and 79,
respectively. Furthermore, one can observe that the curves for δ = 3 and δ = 5 seem to be equal to 0 which is
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Figure 4.1: Kaplan Meier curves of the treatment group with different choices of δ
not possible from a mathematical point of view. In fact the probabilities for those curves are close to zero but
not equal. If this were the case it were caused by the machine epsilon.
For the tipping point analysis the imputed observations are combined with the observed events which have
event times according to the KM curve with δ = 1.
The decrease of the difference with an increase of δ of the actual tipping point analysis can be seen in fig-
ure 4.2.
The reference curve is the one for δ = 1 which is based on the the CAR imputed data set and not the original
data set without the imputations. Since taking the Kaplan Meier KM table to the power of 1 does not change
anything of it, the imputation with δ = 1 is exactly the same as the CAR imputation explained in chapter 3.
The first thing to notice is that independent from the δ, the curves for treatment 2 (the reference group) are all
identical. This was to be expected since the reference group is not affected by the tipping point analysis and
the imputations were done with the same seed.
The changes only affect the treatment group which can also be seen in this figure. With increasing δ, the dis-
tance between the survival curves of the active treatment group and the reference group diminishes. However,
the difference between the curves corresponding to δ = 1 and δ = 3 is much bigger than the difference be-
tween the curves for δ = 3 and δ = 5. This is caused by the fact that the curve which is used to generate the
imputation times rapidly converges to zero as delta increases.
From the results for the HR and the p-value of the LR test, displayed in table 4.1, it can be deduced that
the difference in the survival curves between the active treatment group and the reference group is no longer
significant for a δ = 5.
Generally, it can be observed that for an increasing δ the hazard ratio decreases and hence the p-value increases.
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Figure 4.2: Kaplan Meier curves with δ ∈ {1, 3, 5}
Delta HR Std Err t value p-value
1 0.6081 0.8252 2.59 0.0097
2 0.6466 0.8273 2.23 0.0216
3 0.6748 0.8294 2.05 0.0357
4 0.6945 0.8305 1.93 0.0497
5 0.7101 0.8315 1.86 0.0637
Table 4.1: Results from the tipping point analysis
The procedure stops when the p-value exceeds the significance level of α = 0.05. However, this table only
shows that the true tipping point lies in the range of 4 and 5. As stated before, the program can be executed a
second time with start=4, maxdelta=5 and a step width of by=0.1. The results for this second run are displayed
in table 4.2.
Delta HR Std Err t value p-value
4 0.6945 0.8305 1.93 0.0497
4.1 0.6957 0.8306 1.96 0.0507
Table 4.2: Results from the tipping point analysis to one decimal place
The p-value for δ = 4 is already very close to 0.05 such that the true tipping point can be anticipated at a value
close to that. The program identifies the tipping point for this data at approximately δ = 4.1. It is approximately
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because there are several steps where a random number generator is used (e.g. bootstrapping and drawing the
random uniform [0,1] value). If the seed value is changed there will be a small variation in the results. The
next step would be to evaluate if this value seems to be clinically plausible [14]. Since this is not a statistical
issue and furthermore, it varies from case to case, this question will not be dealt with in this thesis.
The change of the estimated survival curve for the active treatment group with δ = 4.1 from the Kaplan Meier
curve for δ = 1 is illustrated in figure 4.3.
Figure 4.3: Kaplan Meier curves with δ ∈ {1, 4.1}
The difference between curves for the active treatment groups (treatment=1) does not seem very big but suffices
for the difference between the treatment and the reference group to turn no longer significant. The δ = 4.1 can
be interpreted as patients of the active treatment group who drop out of the study have a 4.1 times increased
hazard compared to patients remaining in the study. This signifies a hazard ratio of 1/4.1 = 0.244 for patients
with events during the study compared to patients who were censored throughout the study.
An imputation separated by stratum and treatment is also possible to be investigated via the tipping point anal-
ysis. But since the data set used for the previous analyses consists of a stratum group of the data set introduced
earlier there would be no difference to the already shown tables and graphs.
4.1.3 When no tipping point exists
As mentioned before, there is no guarantee for finding a δ which makes the difference between the treatment
groups become no longer significant. An example can be given by using the complete data set introduced in
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section 3.1. Figure 4.4 shows the Kaplan Meier curves for δ equal to 1 and 100.
Figure 4.4: Kaplan Meier curves with δ ∈ {1, 100}
The difference between the curves for δ = 1 and δ = 100 is very small compared to the increase of the δ.
The reason for this behaviour is the convergence of the curves used to find the imputation times towards 0
for an increasing δ. If the δ could be set to infinity, the imputation time would be the time point for the next
event (by treatment and/or stratum) after the observed censoring. Rothmann et al. and Zhao et al. call this
the worst-comparison analysis [21] [35]. To get an impression of how this curve could roughly look like all
censored values were imputed at the same day where the censoring happened, only the censoring variable is
changed from 1 (censoring) to 0 (event).
These curves can not be produced by the program since the censored survival time is always imputed by an
event time later than the censoring. Figure 4.5 shows how the Kaplan Meier curves would look like if all cen-
sored values would be imputed by an event at the day of the censoring. Again, this is not a realistic scenario
but it can give an impression of how close the survival curves could get at the extreme. The hazard ratio can
provide more detailed information about the difference between the treatments. The results are listed in table
4.3.
HR Std Error Lower CI Upper CI t value p-value
Treatment 1 vs. treatment 2 0.7657 0.8684 0.5807 1.0101 1.9057 0.0586
Table 4.3: Analytical values for setting censorings as events
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Figure 4.5: Kaplan Meier curves with censorings for the active arm imputed as events at day of censoring
The most important observation of this table is the lower confidence bound. The CI only just includes 1. The
test if the point estimate for the HR is different from 1 has a p-value of 0.0586 so the difference between the two
treatment groups is barely not significant with a significance level of 5%. Having in mind that this case cannot
be handled by the program, it is highly doubtful that the tipping point analysis could overturn the conclusion
of significance.
In conclusion, tipping point analysis can be used if the censored values are expected to have a true mean event
time that is smaller than the actually observed mean event time in the same group. The δ is increased as long
as the difference between the treatment groups is significant. If a δ results in a difference that is no longer
significant, it is called the tipping point. If this tipping point is not clinically reasonable, the results may be
judged robust against the CAR assumption [14].
It is not always possible to determine a tipping point since it might be the case that there is no δ such that the
difference between the survival curves is no longer significant. This can be due to a small number of censorings
or a strong treatment effect.
4.2 Reference-based imputation
Whereas the tipping point analysis presented in the previous section is a rather theoretical approach, the
reference-based imputation introduced in this section is more based on practical considerations.
If patients drop out of a study and therefore are censored they will no longer receive the active treatment any
more. For those observations, it is assumed that from this moment on they behave like patients that were as-
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signed for the reference group, that is as if they are administered the reference treatment (this is because in
oncology, the reference treatment is typically the existing standard of care). This assumption serves as a basis
for the reference-based imputation. Hence, the values which are used to impute the censored observations are
obtained from the estimated KM curve for the patients in the reference group. The idea for this assumption is
taken from [20] [19].
4.2.1 Implementation
Only small changes in the introduced program are needed for the realization of the current approach. In the
call statement of the main(·) macro only one additional option has to be added: the control= statement. If it is
defined as NO the CAR imputation is done as before. Changing it to YES will activate the imputation process
according to the above mentioned assumtions, implemented in the adjustment macro. As first step, the Kaplan
Meier table for the reference group is duplicated and replaces the KM tables for all other the treatment groups.
Only the strat variable is a combination of the treatment and stratum is maintained for each group. Figure 4.6
is a schematic representation for an example with 2 treatment groups only that illustrates which KM curves are









Figure 4.6: Schematic representation of the reference-based imputation
The schema shows that the censored observations of both, active treatment and reference group are imputed
according to the KM curve which is estimated on the basis of the events in the reference group only.
If the imputation shall be done for each stratum separately, the KM tables for the treatment groups within one
stratum are replaced by the KM tables of the reference group in this very stratum.
4.2.2 Results
For the comparison of the results obtained by the reference-based imputation vs. the results of an imputation
under CAR, the final KM curves of both methods are plotted in a common plot (figure 4.7).
The difference between the KM curves for the reference group is negligible for the reason that the imputation
process for this group is the same for both approaches. When comparing the curves for the active treatment
group, one can observe that some of the jumps in the curve resulting from the reference-based imputation are
not existing in the curve for the imputation under CAR for the active treatment group. This can be explained
by the fact that the Kaplan Meier curve used to find the imputation times for the active treatment group is
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Figure 4.7: Comparison of the final KM curves for reference-based imputation and imputation under CAR
calculated from the reference group. This means a jump in the Kaplan Meier curve for the reference-based
imputation is either an actual event observed in this group or a censoring which has been replaced with an
event observed in the reference group.
As the difference between the curves produced for the tipping point analysis with δ = ∞ and the ones for the
imputation under CAR was much larger and still the difference between the survival curves of active treatment
and reference group wasn’t significant, it is not surprising that also the survival curves for the two treatment
groups do not differ significantly after the reference-based imputation has been applied. The results may be
seen in table 4.4.
Data Hazard ratio Lower CI Upper CI t value p-value
CAR 0.5591 0.4140 0.7552 3.80 0.0001
Reference 0.5993 0.4510 0.7966 3.53 0.0004
Table 4.4: Comparison of analysis results for original data and reference-based imputed data
In comparison with the original data, the hazard ratio after the imputation is smaller and the p-value is bigger.
However, the p-value still indicates a significant difference in the survival curves at a significance level of 5%.
This shows that even if patients who drop out of the study are followed up until the end of the trial under the
assumption that they receive the reference treatment and thus they are included in the final analysis, the dif-
ference between the treatment groups is still significant. Consequently, the primary analysis based on the one
final data set can be considered robust against informative censoring.
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A comparison between the reference-based approach and the tipping point approach can be drawn by find-
ing a δ that produces approximately the same hazard ratio and p-value. Using δ = 1.57 results in a HR of
0.6048 and a p-value of 0.0003, so reference-based imputation is approximately similar to a delta adjustment
of 1.57.
Figure 4.8: Comparison of final KM curves for reference-based imputation, delta adjustment with δ = 1.57
and imputation under CAR
Figure 4.8 shows that the two curves for the active treatment groups obtained according to the reference-based
imputation or the tipping point approach respectively are very close. The reason why the curves do not exactly
coincide and would not be identical either if the hazard ratios would be equal is again that the reference-based
imputation uses the Kaplan Meier curve of the reference group for the imputation of the censorings in the active
treatment group.
Whereas the Kaplan Meier curves estimates the probability of not experiencing an event up to a certain time
point. The reference-based imputation allows the illustration of an estimation of the reduction in the survival
probability for a patient that drops out of the study for a reason related to the treatment effect compared to a
patient that is continuing the study in the active treatment group 4.9.
One difference in the KM curve for the reference group compared to ones in the previous plots is that the curve
ends at day 672. This is because the censorings are not taken into account when plotting the curve. Besides,
the KM curve for the reference group is exactly the same as in all other graphs so presented.
The vertical line drawn at day 207 marks the point where the hypothetical patient drops out and consequently
his survival probability is no longer estimated on the basis of the data for the active treatment group but on the
data for the reference group. Up to that time the survival curve for the active treatment and the composite curve
are identical and begin to differ only afterwards.
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Figure 4.9: Composite graph compared to active treatment and reference under CAR
The curve referred to as ”composite” graph can be interpreted as the hypothetical Kaplan Meier curve of a pa-
tient who drops out of the study at day 207 and from then on receives the reference treatment. Its ’Hypothetical’
character results from the fact that the curve starts at day 0 when it is neither known whether the patient will be
having an event or a censoring nor if it will be at that exact day 207. If it would be known for a patient that he
is censored at that day and a new Kaplan Meier curve is to be calculated, the curve would start at 1 again since
the patient surely did not experience an event until the day of the censoring.
At the time of the drop out the survival probability in the reference curve is lower than in the active treatment
curve. To be able to construct this composite graph the KM table of the reference group is multiplied such that
the survival probability at day 207 is equal to the survival probability in the active treatment group at that day.
The next step is to combine the KM table of the active treatment group up to day 207 with the stretched KM
table of the reference group containing only observations after this day.
4.3 Pattern imputation
4.3.1 The censorings
The first two approaches presented in this chapter are based on assumptions that concern all of the censored
values in the treatment group. Realistically, patients drop out of a study for various reasons. Forming patterns
of patients who leave the study for the same reason can give a more realistic idea of how the data might have
looked without censorings.
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The data set used in this thesis includes the following reasons for censorings:
1. No post-baseline imaging, alive and no progression during the trial
2. No post-baseline imaging, death or progression after second scheduled imaging
3. New anti-cancer therapy
4. Two or more consecutively missed images immediately prior to death
5. Alive and no progression at time of analysis
The first two cases already always occur for censorings at day 1 which means the patients were recruited and
randomized but did not participate at any further examination. In the fourth case, it is known that the patient
has died during the study but since two or more follow-up examinations are missing prior to the documentation
of the death, the exact time of death or progression is not known. The last reason for a censoring is that the
patient did not have an event or progression until the end of the study.
Reason Overall Treatment Reference
Frequency Percent Frequency Percent Frequency Percent
1 6 6.06 2 3.70 4 8.89
2 6 6.06 2 3.70 4 8.89
3 61 61.62 28 51.85 33 73.33
4 2 2.02 2 3.70 0 0
5 24 24.24 20 37.04 4 8.89
Table 4.5: Frequencies of censorings by cause overall and separated by treatment
Table 4.5 presents the distribution of the censorings by their causes. With 61 out of 99 censorings over both
treatment groups, a new anti-cancer therapy is the most frequent reason for drop out. The second biggest group
consists of patients that did not have an event in the ongoing study.
Before giving examples of forming patterns for those censorings, the imputation process for the different pat-
terns is explained and its implementation on the basis of the previously introduced programs is described.
4.3.2 The instruction data set
The curves and the imputation macros remain unchanged.
For the implementation of the previous approaches it was sufficient to specify one additional parameter (δ for
the tipping point approach and control=YES for the reference-based imputation) to be able to do the imputation.
For the imputation by patterns, one can specify a different δ for each pattern and every treatment group within
this pattern. Alternatively, it is possible to select the Kaplan Meier curve for an arbitrary treatment group in
the study to impute a specific pattern. And the program is able to use any Kaplan Meier curve and additionally
apply a δ to this curve specifically for each pattern.
To make this possible without changing the call of the macro too much every time a different data set or
different pattern shall be used, an instruction data set is created. For each pattern this data set contains the value
for δ and the code for the treatment group which is used to calculate the Kaplan Meier curve for the imputation
in a separate row. An example of how this data set could look like in the case of only two patterns is given in
table 4.6. In general, the number of rows in the instruction data set equals the number of different patterns for
the imputation.
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Treatment 1 Treatment 2
Pattern Delta1 Switch1 Delta2 Switch2
1 2 1 1 2
2 1 2 1 2
Table 4.6: Example for the instruction data set
The first row is just added for explanation and does not exist in the actual data set. The columns in the second
row have to be named exactly as they are in the table since they are used by the program to identify the columns.
In case there are more than two treatments, the numeration of the names is continued (Delta3, Switch3, Delta4,
Switch4, . . .). The ”pattern” column also needs to be included in the data set so the program knows which line
to use.
Treatment 2 is imputed similarly in both patterns: there is no delta adjustment added since Delta2 is equal to 1
in both cases and both patterns specify the KM curve of treatment 2 to be used for the imputation. This means
the second treatment is imputed under the CAR assumption for both patterns as they are imputed using their
own KM curve and δ = 1.
The imputation of treatment 1 differs between the two patterns. In pattern 1 the KM curve of treatment 1 is
used, so no switching of treatment groups is planned. ButDelta1 = 2 specifies a delta adjustment for treatment
1 with δ = 2 in pattern 1.
The second pattern includes no delta adjustment for treatment 1 (Delta1 = 1) but the imputation is planned to
be done with the KM curve of treatment 2 (Switch1 = 2).
In summary, if treatment 2 is chosen as the reference group, pattern 1 is imputed by means of a delta adjustment
with δ = 2 whereas for pattern 2, a reference-based imputation is applied.
4.3.3 Implementation
The actual implementation of the pattern imputation is done by a modified version of the main macro, called
newmain. The changes to the main macro are small but very important for the further course of the pattern
imputation approach.
Apart from the original data, the newmain macro additionally imports the instruction data set and saves the
number of treatment groups in the variable nvar.To regulate the order for the imputation process, a consequtive
number is assigned to every stratum within each treatment group and pattern by means of the variable ”pat-
tern”. Table 4.7 takes up the example for the strat variable given in table 3.1 and illustrates the numbering for
two patterns, treatment groups and strata.
Pattern 1 Pattern 2
Treatment 1 Treatment 2 Treatment 1 Treatment 2
Stratum 1 1 3 5 6
Stratum 2 2 4 7 8
Table 4.7: Example of numbering contained in the pattern variable
Numbering the groups in this way enables the program to impute the patterns one after the other.
Another purpose of the newly created pattern variable is to specify the division of all censorings extracted from
the original data set into the separate censoring data sets. In the main macro, this separation has been conducted
according to the strat variable.
The macro for the adjustments for the pattern imputation approach is called pmmadjustment. It is able to make
use of the instruction data set and the information about the number of treatments saved earlier in the variable
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nvar. The pmmadjustment macro creates the data set kmcurves that contains all KM tables that are used for the
imputation. Since every pattern can define the KM curve which has to be used for all treatments, the kmcurves
data set contains as many KM curves as the number of treatment groups multiplied with the number of patterns,
if no stratified analysis is done. In detail, for every treatment group in every pattern the pmmadjustment macro
defines the KM curve of the treatment defined in the switch column as the KM curve for imputation for this
specific pattern. After the KM table defined in the instruction data set is inserted as KM table for the pattern
group it can be calculated to the power of the δ defined for this group in the instruction data set.
The program is able to impute the pattern appropriately as long as the instruction data set has a proper structure.
The challenge for the user is to find patterns that are clinically reasonable. In the following three examples of
patterns are given.
Pattern example 1
Table 4.5 reveals that the most frequent reason for drop outs is a new anti-cancer therapy. It may be assumed
that patients from the reference group (treatment 2) receive a ”better” treatment (that it is similar to the trial
active treatment) and the patients from the active treatment group (treatment 1) a ”worse” treatment than they
did up to the drop out. Based on this assumption the instruction data set can be constructed as displayed in
table 4.8.
Treatment 1 Treatment 2
Pattern Delta 1 Switch 1 Delta 2 Switch 2
1 1 2 1 1
2 1 1 1 2
Table 4.8: Instruction data set for pattern example 1
Pattern 1 includes all censorings that drop out due to a new anti-cancer therapy. In this pattern, censorings
in treatment group 1 are imputed using the KM curve from treatment 2 and vice versa. The second pattern
includes all other censorings which are treated as censored at random by the imputation program.
Figure 4.10 shows the KM curves of this first example using a pattern imputation compared to the usual CAR
imputed KM curves. The first thing to mention is that the curves of the reference group are different. In the
previous approaches, the assumptions were focused on the active treatment group. The pattern imputation
allows assumptions for the reference group as well. In this case it is assumed that patients in pattern 1 who
drop out of the reference group receive the active treatment starting at the point of drop out. This change in
treatment is the reason for the pattern imputed curve being above the curve of the CAR imputed reference
group. In contrast to this, the curve of the pattern imputed active treatment group is below the curve of the
CAR imputed active treatment group.
The log hazard ratio and other analytic parameters for the pattern imputed data set are displayed in table 4.9.
HR Standard error 95% CL t value p-value
0.7175 0.8700 0.5460 0.9427 2.39 0.0172
Table 4.9: Pooled results from pattern imputation for pattern example 1
Since the imputed event times are better than the average in the reference group and worse than the average
in the treatment group, the HR is smaller than in the original analysis of the data. The p-value of 0.0172 does
indicate a significant difference between the treatment groups at a 5% significance level.
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Figure 4.10: KM curves for pattern example 1 comparing pattern imputation with CAR imputed KM curves
Pattern example 2
The reason ”new anti-cancer therapy” is used again for another assumption to create patterns. This time,
patients in the reference group will be assumed to be censored at random. The patients of the active treatment
group which left the study for a new anti-cancer therapy are assumed to have the same risk as the patients in
the reference group. Patients who were censored for other reasons are allocated to the second pattern and are
imputed according to the CAR assumption. The instruction data set for this example can be found in table 4.10.
Pattern Delta 1 Switch 1 Delta 2 Switch 2
1 1 2 1 2
2 1 1 1 2
Table 4.10: Instruction data set for pattern example 2
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The difference from example 1 is that the censorings of the reference group in pattern 1 are imputed using the
KM curve of the reference group and not the one from the active group.
Figure 4.11 shows the Kaplan Meier curves of the pattern imputed data and the CAR imputed data.
Figure 4.11: KM curves of example 2 of pattern imputation compared with CAR imputed KM curves
The small difference that can be observed between the curves of the reference group can be explained by the
the fact that the pattern imputation imputes two groups of censorings separately from each other which leads to
a higher variation in the imputation times as the KM curves for the imputation are based on a smaller number
of observations.
The results from the mianalyze procedure are shown in table 4.11.
HR Standard error 95% CL t value p-value
0.5842 0.8668 0.4413 0.7734 3.76 0.0002
Table 4.11: Pooled results from pattern imputation for pattern example 2
Comparing the log HR with the results of the analysis for the reference-based imputation (log HR of 0.5043,
compare table 4.7) shows that the difference between the two treatment groups is bigger if only the censorings
in pattern 1, are imputed using the reference-based method and the censorings in pattern 2 are imputed under
the CAR assumption.
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Pattern example 3
The third example is the most discriminating and demonstrates the flexibility of the pattern imputation. All
causes for the drop outs are considered for setting up the patterns.
As before, the first pattern is formed by the drop outs due the administration of a new anti-cancer therapy. For
this third example, the new therapy is assumed to have at best an equal effect equal to the reference treatment.
This means that the censorings of all patients in this pattern, are imputed according to the KM curve of the
reference group which is additionally worsened by choosing a small δ. The δ is applied because it is assumed
that the disease of patients who drop out of the study to get another therapy is worse compared to the patients
who stay in the study.
The next smallest group compromises the censorings due to reasons 1 and 5. In both cases, the patients are
known to be alive at the end of the trial and were not diagnosed with a progression during the trial. Because of
that, censoring at random is proposed: no adjustments to the KM curves are made. In the following description,
it is referred to as pattern 2.
Pattern 3 is formed by patients who are censored because of death or progression after second scheduled
imaging (compare reason 2 in section 4.3.1). This means that the patients are recruited for the study but no
post-baseline imaging was carried out for them. The only available information is that death or progression
has occured after the second scheduled imaging. The underlying assumption for the imputation is that those
patients have a highly increased risk for an event compared to the treatment and stratum group they belong to.
Therefore, a high delta (5) is applied to the KM curve of this pattern.
The last pattern consists of only two patients: those who missed two or more consecutive images immediately
prior to death. Creating a separate pattern for two censorings may not influence the results too much but there
is no minimum number of censorings that a pattern needs to contain. Since it is known that the patients in this
pattern died during the study, again a high delta is applied to the KM curve of this pattern.
All these explanations lead to the instruction data set displayed in table 4.12.
Pattern Delta 1 Switch 1 Delta 2 Switch 2
1 2 2 1 2
2 1 1 1 2
3 5 1 5 2
4 7 1 5 2
Table 4.12: Instruction data set for pattern example 3
Imputing the censorings according to these patterns results in the Kaplan Meier curves as shown in figure 4.12.
Both curves of the pattern imputation are below the respective curves of the CAR imputation. The difference
between the pattern imputation and the CAR imputation is larger for the active treatment group. Furthermore,
for most of the patterns it is assumed that the patients who drop out of the study would do worse than the average
of the uncensored patients. This is especially true for the patients in the activee treatment group. Therefore
the influence of the imputed censorings on the KM curve of the active treatment group is stronger. Another
reason is that for pattern 1, the censorings in the active treatment group are imputed using the KM curve of the
reference group and additionally a δ of 2 is applied.
The results of the final analysis for the pattern imputed data set are displayed in table 4.13.
The results show a clearly significant difference in the survival curves at a 5% significance level. Specifying
the patterns this way is complicated, requires time and clinical experience to figure out optimal specifications
for each pattern. The advantage of this patterning is that the outcome of the imputation is potential realistic.
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Figure 4.12: KM curves of example 3 of pattern imputation compared with CAR imputed KM curves
HR Standard error 95% CL t value p-value
0.6007 0.8669 0.4538 0.7951 3.57 0.0004
Table 4.13: Pooled results from pattern imputation for pattern example 3
In conclusion, pattern imputation allows the application of imputation methods based on different assump-
tions to predefined patterns. The program written in the course of this thesis is not only able to apply specific
δ’s to different treatment groups within a pattern, it can also select an arbitrary Kaplan Meier curve that can be
calculated on the basis of the provided data set for the imputation of a certain set of censorings.
With realistic assumptions based on clinical knowledge and reasonable patterns, the program gives an impres-




This thesis takes up the idea of multiple imputation for time-to-event data under the censoring at random as-
sumption and uses it as a basis for the development of sensitivity analyses that can be applied if informative
censoring is assumed.
Multiple imputation procedures for time-to-event data are not very popular. The reason for that is that most
analysis methods require the assumption of censoring at random. However, if multiple imputations are done
under this assumption, the analysis of the imputed data will produce the same results as the analysis of the orig-
inal data [30]. Hence, the imputation process doesn’t add too much benefit but affords one additional working
step and increases the standard error. Nevertheless, a program that implements multiple imputation under the
assumption of censoring at random serves as a starting point for the main part of this thesis which is the imple-
mentation of 3 different approaches how to use multiple imputations for a sensitivity analyses to informative
censorings in the statistical analysis software SAS. Independent from the respective censoring assumption, all
implemented programs use the Kaplan Meier imputation introduced by Taylor et. al. [30] to generate the im-
putation times.
Generally, all programs enable the user to realize the implementation separated by treatment and possible strat-
ification variables or by the treatment only. If using the implementation by stratification factors one has to be
careful with the size of the stratification groups. If a group has not enough events the Kaplan Meier curve for
the KMI of this group is poorly defined. This can lead to imprecise outcomes of the imputation and therefore
imprecise results. Nonetheless, if there is a satisfying number of events in every group the stratified imputation
uses more information about the data and the results are more precise.
After the implementation of the imputation under CAR has been accomplished, the code has been validated by
comparing the produced results with the results of the original data. As expected, the estimated hazard ratios
showed satisfying similarity. The small difference between the results of the original and the imputed data
are assumed to be caused by the number of events. This assumption is based on the observations made for
the equivalence test. For this test data sets with 2000 patients each were used and the differences between the
hazard ratios of the original and imputed data were much smaller than in the example data set for this thesis
which consists of 345 patients overall. If there would be an infinite number of events the Kaplan Meier curve
would give a closer estimation of the Survivor function, assuming there is no bias, which is directly linked to
the distribution of the events and therefore the imputation of the censored observations would be done accord-
ing to exactly the same distribution like the censorings. This is no failing of the bootstrap since the bootstrap
used in this thesis sampled the existing observations from the original data set and did not create new event or
censoring times. Increasing the number of imputations will lead only to slightly closer results from a certain
number of imputations on.
One reason for different results could be non proportional hazards as suggested by Zhao et al. [35]. In a study
with a high censoring rate and a bigger treatment effect early on in the study the estimation of the hazard ratio
may tend to be mainly influenced by events from the earlier part of the study. The Kaplan Meier imputation
method puts more weight on the later part of the study by imputing potential event times. This can lead to
hazard ratios with smaller effect for the active treatment group (closer to 1) after the imputation. This means
that the Kaplan Meier imputation under the CAR assumption can be useful for the evaluation of implications
of non proportional hazards during a study [35]. Since the difference between hazard ratios of the imputed and
the original data set are relatively small there is no evidence of big violation for the proportional hazards as-
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sumption. However, the results do not confirm the assumption, there is still the possibility of non proportional
hazards in this data that could not be detected by the CAR imputation method.
Contrary to this, the values for the log-rank statistic diverge from each other. The reason was found in the fact
that the test statistic takes into account the number of events. Since the imputation results in a higher amount of
events, this causes the difference in the log-rank statistics. It may be possible to adjust the statistic by applying
a factor related to the number of events before and after imputation to it. This is a possible topic for further
investigations as it was not a part of this thesis finding such a factor.
However, an alternative is to compare the p-values of the log-rank test before and after the imputation as it
is done in several publications [31][14][30]. The difference between the p-values can be explained with the
same reasons for the differences between the hazard ratios. Additionally, this explanation has been confirmed
numerically by conducting an equivalence test for a simulated data set with no censorings and the same data
set for which some observations have been censored artificially and have been imputed afterwards by means of
the written program. The boundaries of [-3.5,3.5] imply an allowed divergence of 1% relatively to the mean of
the log-rank statistics of the non-censored data set. Since the TOST was made with 100 data sets the deviation
in the respective groups is quite high which leads to a standard error of 0.952 for the mean difference between
the log-rank tests of imputed and complete data sets. If the TOST would be done using more data sets to get a
smaller standard error it may be possible to specify smaller boundaries to get more sensitive results. For this
case boundaries with ±1% seem appropriate.
The test was able to show that the difference in the log-rank statistic before and after the imputation is mostly
caused by the increased number of events after the imputation.
In general, the CAR imputation works and can be used to impute time-to-event data sets. Since this thesis was
limited in time there are options that could not be included but are worth to be mentioned. The first point is
concerning the analysis of the imputed data sets which does not offer the possibility to add covariates for the
Cox proportional hazards model. Variables other than the treatment group can only be included as stratification
factors and so, no parameter estimates can be calculated, so the influence of the variables cannot be measured.
For the imputation itself, the Kaplan Meier imputation is the only imputation method. Other imputation meth-
ods could be included in the program as well, for example the risk set imputation which has been introduced in
section 2.3.2.
Another reason for differences in the results for both the hazard ratio or the log-rank test could be an insufficient
number of imputations. All results in this thesis were produced using 100 imputed data sets. If no bootstrap is
used this number should give stable results but a bootstrap brings a higher variance with it. A higher number
of imputations should result in more stable point estimates and reduced variance. This could not be done in the
thesis due to the long run time for higher imputation numbers than the used 100. Nonetheless, the use of the
bootstrap makes sense since it gives a better estimate for the variance.
Since the Kaplan Meier imputation method is used one could think about implementing an option to ”specify”
an external Kaplan Meier curve to be used in the imputation process. This can be useful for example if patients
drop out because they receive another therapy. In this case the survival times could be imputed according to
the KM curve of this new treatment which can be taken from the respective trial. It could also be used if there
is a subgroup of censored patients with characteristics that have been examined in another trial.
A problem with the Kaplan Meier imputation is that for the last censorings that occurred in the study only few
events remain to calculate the corresponding Kaplan Meier curves or no events remain at all if the censorings
occur after the last event. This can lead to imprecise results. Zhao et. al suggest an exponential model for the
conditional survivor function for the last few events. For a censoring time ck after the last event this would be
Ŝ(ck) = Ŝ(tM ) ∗ exp(−h ∗ (ck − tM )), where h denotes the hazard assumed for the censored observations
50
CHAPTER 5. DISCUSSION
[35]. This could not be included in this thesis due to the restricted time but could be an interesting point for
possible extensions of the implemented program.
The basic idea for the imputation of informative censoring is to modify the KM curves used for the KMI ac-
cording to the assumptions for the informative censoring. Zhao et. al proposed to add the power of a δ > 1
to the KM curve and thus to simulate a deterioration of the survival times of the drop outs [35]. This delta
adjustment can be used as sensitivity analysis for informative censoring. O’Kelly used the delta adjustment to
perform a tipping point analysis [14], which is the first approach realized in this thesis.
The delta adjustment method is useful if the difference between the treatment effects is small and informative
censoring is assumed for the active treatment group. Since this method ”searches” for the δ which worsens the
active treatment group so much that it is no longer significant it would make sense to pre specify a δ with a
medical expert as threshold for the sensitivity analysis. This is because the term ”clinically reasonable” can be
subjective depending on what needs to be shown.
Zhao et al. choose δ = 2.5 as upper bound which corresponds to a hazard of 0.4 comparing treatment vs.
placebo as represents a reasonable effect size for a clearly effective treatment for their example [35].
The main target of a tipping point analysis is to find a δ that makes the treatment effect no longer significant.
This can not always be achieved as shown in section 4.1.3. But even this scenario gives information, which is
that the treatment effect is that strong that even the worst-comparison analysis cannot reduce it to a not signifi-
cant level.
For that reason a subgroup was used in this thesis which had a smaller treatment effect. The tipping point
analysis ended successfully at δ = 4.1. This implies that the hazard ratio of patients staying in the active treat-
ment group vs. censored patients is 1/4.1 = 0.24 which is unlikely. In conclusion, even a more marginally-
significant subgroup of the provided study with smaller treatment effect can be judged robust for informative
censoring when using the tipping point method as sensitivity analysis.
One option that has not been examined in this thesis is a delta adjustment with a δ < 1. Such a parameter
value for δ would signify that patients who drop out of a study are assumed to have later event times than un-
censored patients. This can be appropriate for a trial where patients in the reference group may receive rescue
medication. If that is the case they will do better after the drop out because of it. The imputation could be done
by means of the KM curve for the reference group and a δ < 1 to simulate this. The reason for ignoring this
option is that this thesis focused on sensitivity analyses where it is typically not assumed that censored patients
actually do better after drop out. If one wanted to apply it has to be handled carefully. The assumption of an
improvement after drop out needs strong evidence.
The second approach is based on an idea presented by Roger, a reference-based imputation for longitudinal
data [19][20]. This idea was transferred to time-to-event data, which means that patients who drop out of the
active treatment group behave like the patients of the reference group regarding the event time.
In contrast to the tipping point analysis, the reference-based imputation does not ”search” for a scenario where
the treatment effect is not significant any more. If the treatment effect is still significant after the censorings
have been imputed, the analysis can be considered robust.
Since in most oncology studies the reference group receives the best licensed treatment the assumption of the
reference based imputation are reasonable and applicable in the real world. However, one has to be careful
using it in studies where progression is an endpoint. Patients leaving a study are often in worse health than
patients remaining in the study. It may be that those patients would do even worse than the patients in the
reference group. In this case the actual hazard of censored patients after drop out would be even higher than
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assumed in the reference-based analysis. The pattern imputation method can deal with such assumptions but
not the reference-based analysis. In case it is assumed that patients who drop out actually have the same hazard
than patients in the reference group, the reference based imputation can be considered as sensitivity analysis.
Since the δ in the delta adjustment can be interpreted as hazard after the drop out for censored patients, the
reciprocal of the hazard ratio of the original study could be applied to the active treatment group to imply that
the patients of the active treatment group have the same hazard like the patients in the reference group after
drop out as suggested in Zhao et al. [35]. The study in this thesis hat a hazard ratio of 0.57 comparing active
treatment group vs. reference group which would mean δ = 1.75 for the active treatment group after censoring.
Interestingly, the δ closest to the results of the reference-based imputation in this thesis is 1.57. This difference
can potentially be explained by the fact that the reference-based imputation uses a different distribution (of the
reference group) for the imputation than the active treatment distribution used in Zhao et al.
The reference-based imputation method led to a hazard ratio of 0.599 comparing active treatment vs reference
which is slightly closer to unity than the original study analysis (HR 0.57). But the treatment effect is really
strong, even after the imputation which is also shown with a corresponding p-value of 0.0004. The original
study analysis therefore can be judged robust to informative censoring after applying a reference-based impu-
tation as sensitivity analysis.
It is unlikely that all patients who drop out of a study meet the same expectations with the progress of their
disease after they left the trial. Based on this, the pattern imputation approach was developed and implemented.
The pattern imputation can be used not only as a sensitivity analysis but also to get an impression of how the
results might look like if the data would not have been censored.
The big advantage of the pattern imputation is that different assumptions can be made for theoretically every
censoring. One has to be careful with the number of censorings in the patterns. If there are too much patterns
with a small amount of censorings the outcome of the imputations can be imprecise. This is because different
distributions are defined for each treatment in every pattern. If the imputation procedure produces extreme
values for the imputation time it influences the results much more if there is a small amount of censorings in
this pattern. The combination of imputed observations from different distributions can potentially cause impre-
cision. This is due to less censorings being imputed with more different distributions and therefore the patterns
have a higher variance if they are smaller. This issue can get even more serious if the imputation is planned to
be done separated by a stratification variable. As mentioned in the previous approaches a stratified imputation
decreases the number of events used to calculate the respective Kaplan Meier curves which can influence the
results if the number of events is not big enough.
If there are enough events and enough censorings in each pattern the pattern imputation is a very powerful tool
not only for sensitivity analyses. The usage of the implementation of the pattern imputation is very easy with
the instruction data set.
One problem with the pattern imputation that has not been addressed in this thesis is the construction of the
patterns and the identification of patients belonging to this pattern. The study provided for this thesis included
the reasons for drop out that could be used to form patterns. A manual of how to find patterns of censorings in
time-to-event data could be useful additionally to the imputation program.
In this thesis 3 examples for pattern imputation are given. None of them ended up making the treatment effect
not significant with example 1 being closest to it by switching the Kaplan Meier curves for the KMI for the
treatments. Example 3 for the pattern imputation is the most complex with having 4 patterns with different
assumptions. But is is also the most realistic in points of behaviour after censoring. The hazard ratio of ac-
tive treatment vs. reference treatment is slightly bigger than in the original study results (0.6 after imputation
compared to 0.57 in the original study) but it is not even close to being not significant (p-value=0.0004). This
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example also shows the strength of the pattern imputation. The tipping point analysis and the reference-based
analysis both only give one option for adjusting the Kaplan Meier curve of the active treatment group. The
pattern imputation can handle different assumptions not only for the different treatment groups but also for pre
specified patterns of censorings in one treatment group or even stratum if there are enough observations.
The implementation for the pattern imputation is done with two macros different from those for the first two
approaches. This is due to the working process in this thesis which was started with the tipping point analysis
as first extension to the CAR program because the implementation is the most straight forward. In fact, the
delta adjustment and the reference-based analysis can be done with only the macros for the pattern imputa-
tion. For the first two approaches only one pattern is specified including all censorings where the reference
treatment is imputed under the CAR assumption and the active treatment group is imputed under the respective
assumptions for delta adjustment or reference-based analysis. To get the tipping point analysis working with
the pattern imputation macros the implementation of the macro that increases the δ after every loop would have
to be reworked.
In conclusion, all implemented methods work well and can be used under the right conditions. The assumptions
for the approaches are realistic under the right conditions. For the tipping point analysis the boundaries should
be chosen reasonable. The first two approaches suffer a little under the fact that only the active treatment curve
can be adjusted with only one assumption but nonetheless they are very useful as sensitivity analysis tools and
are relatively simple. Finally, it is noteworthy that the pattern imputation programs provide a method that has
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